Cargando…

Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication

BACKGROUND: Magnetic sphincter augmentation (MSA) is a surgical intervention for gastroesophageal reflux disease (GERD) which has been evaluated in numerous studies and has shown beneficial effects. Long-term effectiveness data for MSA as well as laparoscopic fundoplication (LF) in patients with GER...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonavina, Luigi, Horbach, Thomas, Schoppmann, Sebastian F., DeMarchi, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195805/
https://www.ncbi.nlm.nih.gov/pubmed/32676727
http://dx.doi.org/10.1007/s00464-020-07792-1
_version_ 1783706569986277376
author Bonavina, Luigi
Horbach, Thomas
Schoppmann, Sebastian F.
DeMarchi, Janet
author_facet Bonavina, Luigi
Horbach, Thomas
Schoppmann, Sebastian F.
DeMarchi, Janet
author_sort Bonavina, Luigi
collection PubMed
description BACKGROUND: Magnetic sphincter augmentation (MSA) is a surgical intervention for gastroesophageal reflux disease (GERD) which has been evaluated in numerous studies and has shown beneficial effects. Long-term effectiveness data for MSA as well as laparoscopic fundoplication (LF) in patients with GERD are needed. OBJECTIVE: The objective of this study was to evaluate the 3-year outcomes for MSA and LF in patients with GERD. METHODS: This prospective, multi-center, observational registry study evaluated MSA and LF in clinical practice over 3 years (ClinicalTrials.gov identifier: NCT01624506). Data collection included baseline characteristics, reflux symptoms, medication use, satisfaction and complications. Post-surgical evaluations were collected at yearly intervals. RESULTS: Between December 2009 and December 2014, 631 patients (465 MSA and 166 LF) were enrolled in the registry. Both MSA and LF resulted in improvements in total GERD-HRQL score (mean reduction in GERD-HRQL from baseline to 3 years post-surgery: MSA 22.0 to 4.6 and LF 23.6 to 4.9) and in satisfaction (GERD-HRQL satisfaction increase from baseline to 3 years: MSA 4.6% to 78.2% and LF 3.7% to 76.5%). Most patients were able to belch as needed with both therapies (MSA 97.6% and LF 91.7% at 3 years). MSA allowed a higher percentage of patients the ability to vomit as needed (MSA 91.2% and LF 68.0% at 3 years). PPI usage declined from baseline to 3 years for both groups after surgery (MSA 97.8% to 24.2% and LF 95.8% to 19.5%). The mean procedure time was shorter for MSA than for LF. Intraoperative and procedure-related complication rates (≤ 2%) were low for both therapies. CONCLUSIONS: This 3-year prospective observational registry study contributes to the mounting evidence for the effectiveness of MSA and LF. Despite the more severe nature of GERD in the LF group, the clinical outcomes for MSA and LF were favorable from an effectiveness and safety standpoint.
format Online
Article
Text
id pubmed-8195805
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-81958052021-06-28 Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication Bonavina, Luigi Horbach, Thomas Schoppmann, Sebastian F. DeMarchi, Janet Surg Endosc Article BACKGROUND: Magnetic sphincter augmentation (MSA) is a surgical intervention for gastroesophageal reflux disease (GERD) which has been evaluated in numerous studies and has shown beneficial effects. Long-term effectiveness data for MSA as well as laparoscopic fundoplication (LF) in patients with GERD are needed. OBJECTIVE: The objective of this study was to evaluate the 3-year outcomes for MSA and LF in patients with GERD. METHODS: This prospective, multi-center, observational registry study evaluated MSA and LF in clinical practice over 3 years (ClinicalTrials.gov identifier: NCT01624506). Data collection included baseline characteristics, reflux symptoms, medication use, satisfaction and complications. Post-surgical evaluations were collected at yearly intervals. RESULTS: Between December 2009 and December 2014, 631 patients (465 MSA and 166 LF) were enrolled in the registry. Both MSA and LF resulted in improvements in total GERD-HRQL score (mean reduction in GERD-HRQL from baseline to 3 years post-surgery: MSA 22.0 to 4.6 and LF 23.6 to 4.9) and in satisfaction (GERD-HRQL satisfaction increase from baseline to 3 years: MSA 4.6% to 78.2% and LF 3.7% to 76.5%). Most patients were able to belch as needed with both therapies (MSA 97.6% and LF 91.7% at 3 years). MSA allowed a higher percentage of patients the ability to vomit as needed (MSA 91.2% and LF 68.0% at 3 years). PPI usage declined from baseline to 3 years for both groups after surgery (MSA 97.8% to 24.2% and LF 95.8% to 19.5%). The mean procedure time was shorter for MSA than for LF. Intraoperative and procedure-related complication rates (≤ 2%) were low for both therapies. CONCLUSIONS: This 3-year prospective observational registry study contributes to the mounting evidence for the effectiveness of MSA and LF. Despite the more severe nature of GERD in the LF group, the clinical outcomes for MSA and LF were favorable from an effectiveness and safety standpoint. Springer US 2020-07-16 2021 /pmc/articles/PMC8195805/ /pubmed/32676727 http://dx.doi.org/10.1007/s00464-020-07792-1 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bonavina, Luigi
Horbach, Thomas
Schoppmann, Sebastian F.
DeMarchi, Janet
Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
title Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
title_full Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
title_fullStr Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
title_full_unstemmed Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
title_short Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
title_sort three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195805/
https://www.ncbi.nlm.nih.gov/pubmed/32676727
http://dx.doi.org/10.1007/s00464-020-07792-1
work_keys_str_mv AT bonavinaluigi threeyearclinicalexperiencewithmagneticsphincteraugmentationandlaparoscopicfundoplication
AT horbachthomas threeyearclinicalexperiencewithmagneticsphincteraugmentationandlaparoscopicfundoplication
AT schoppmannsebastianf threeyearclinicalexperiencewithmagneticsphincteraugmentationandlaparoscopicfundoplication
AT demarchijanet threeyearclinicalexperiencewithmagneticsphincteraugmentationandlaparoscopicfundoplication